Watch a slew of vintage MTV from the 1980s / Boing Boing

Archive.org contributor Windsinger is uploading their entire VHS collection of MTV recordings from the channel’s finest era, from its launch on August 1 1981 until 1989 (with a few 1991 episo…

Fonte: Watch a slew of vintage MTV from the 1980s / Boing Boing

Coronavírus: aprovadas medidas de proteção ao guerreiros e guerreiras da área da saúde que estão salvando vidas | Revista Fórum

Leia na coluna de Alexandre Padilha: “Hoje, o maior risco de colapso do sistema de saúde tem a ver com a infecção dos trabalhadores e trabalhadoras da saúde”

Fonte: Coronavírus: aprovadas medidas de proteção ao guerreiros e guerreiras da área da saúde que estão salvando vidas | Revista Fórum

Coronavirus in California: Newsom Orders Beaches Closed | The Loppy

http://www.nytimes.com Good morning.(Don’t get California Today delivered to your inbox? Here’s the sign-up.)On Thursday, Gov. Gavin Newsom declared there would be a “hard close” of state and local beaches in Orange County.“I’m a beach advocate,” Mr. Newsom said. But he added that maintaining access to t

Fonte: Coronavirus in California: Newsom Orders Beaches Closed | The Loppy

São Paulo: secretário de Saúde de admite possibilidade de lockdown – Brasil 247

O secretário estadual de Saúde de São Paulo, José Henrique German, admitiu que o lockdown poderia ser adotado em São Paulo como medida para conter o avanço da Covid-19

Fonte: São Paulo: secretário de Saúde de admite possibilidade de lockdown – Brasil 247

Remdesivir for COVID-19: challenges of underpowered studies – The Lancet

In The Lancet, Yeming Wang and colleagues1 report a randomised trial of remdesivir(200 mg on day 1 followed by 100 mg on days 2–10, in single daily infusions) versusplacebo for adults with severe coronavirus disease 2019 (COVID-19) in ten hospitalsin Wuhan, China. The authors report on 236 patients (140 [59%] men and 96 [41%] women;median age 65 years [IQR 56–71]), with inconclusive findings on the primary outcomeof time to clinical improvement, defined as a two-point improvement on a 6-point ordinalscale,2 a hazard ratio of 1·23 (95% CI 0·87–1·75; favouring remdesivir), and medianobservation times of 21 days (IQR 13–28) in the remdesivir group versus 23 days (15–28)in the placebo group (a non-significant difference).

Fonte: Remdesivir for COVID-19: challenges of underpowered studies – The Lancet